KA Imaging Makes Distribution Deal with Malaysia Based BeyMed

KA Imaging has entered into a distribution agreement with BeyMed for distribution of KA imaging innovative dual-energy imaging solution Reveal™ 35C in the Malaysian market.

“KA Imaging is excited to be growing rapidly and providing innovative diagnostic imaging solutions worldwide, this time signing a distribution agreement to cover Malaysia. BeyMed is an emerging medical solutions company with a great potential,” said Amol Karnick, President and CEO of KA Imaging.

BeyMed values offering modern, effective problem-solving through innovative technologies and strives to provide quality technology and diagnostic solutions to support radiological practices thus minimizing diagnostic errors.

Gandhi Suppiah, Managing Director of BeyMed, stated: “KA Imaging’s Reveal 35C will complement our advanced imaging technology solutions. We are excited to partner with KA Imaging to develop new imaging solutions in this part of the world.”

BeyMed has also secured proof of concept trials that will use Reveal 35C with one of the major hospitals in Kuala Lumpur as part of the imaging solutions model in Malaysia.

Reveal 35C is the world’s first and only portable dual-energy X-ray detector. The detector provides radiologists and medical professionals with three unobstructed images in a single shot with ZERO motion artifacts for better patient care. Reveal is currently being proudly used in a few clinical trials in Canada, for detecting abnormalities like lung cancer and pneumonia (including COVID-19) with great initial success.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”